Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Taiwen Chen

Critical Care Medicine Ocala, FL Medical Doctor

NPI 1629062385 CMS profile 300918

1500 Sw 1St Ave, Ocala, FL 34471

Open in the dashboard

General payments

$20,655

109 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$19,500 paid to institutions, not to them · program year 2019

Through program year 2023, Taiwen Chen of Ocala, FL is reported in the CMS Open Payments database as having received $20,655 across 109 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $19,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $2,428 6
2022 General $5,729 11
2021 General $2,870 18
2020 General $4,455 17
2019 General $5,174 57

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Taiwen Chen
  • Critical Care Medicine median
  • Middle half of Critical Care Medicine
  • National median

In program year 2025, general payments to Taiwen Chen were reported at $0. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.

Show as a table
Year Taiwen Chen Critical Care Medicine median Middle half National median
2019 $5,174 $149 $51–$535 $163
2020 $4,455 $110 $30–$325 $114
2021 $2,870 $125 $34–$403 $132
2022 $5,729 $157 $49–$582 $149
2023 $2,428 $162 $56–$621 $160
2024 $0 $168 $53–$634 $164
2025 $0 $189 $59–$844 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Grifols USA, LLC $14,297 23 payments
  2. Mallinckrodt Hospital Products Inc. $2,150 1 payment
  3. GlaxoSmithKline, LLC. $1,175 44 payments
  4. AstraZeneca Pharmaceuticals LP $837 8 payments
  5. Grifols Shared Services North America, Inc. $660 1 payment
  6. Daiichi Sankyo Inc. $213 2 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $174 7 payments
  8. Insmed, Inc. $145 2 payments
  9. Pacira Pharmaceuticals Incorporated $125 1 payment
  10. Novo Nordisk Inc $125 1 payment
  11. Other $755 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,038 11 payments
  2. Food and Beverage $4,418 94 payments
  3. Travel and Lodging $863 3 payments
  4. Consulting Fee $337 1 payment
Products named General payments · program years 2019–2023
  1. Prolastin-C Liquid $11,803 17 payments
  2. Prolastin-C $3,154 7 payments
  3. ACTHAR $2,150 1 payment
  4. TRELEGY ELLIPTA $849 21 payments
  5. FASENRA $489 4 payments
  6. BREZTRI $240 2 payments
  7. NUCALA $145 4 payments
  8. Arikayce $145 2 payments
  9. EXPAREL $125 1 payment
  10. Ozempic $125 1 payment
  11. Other $1,488 59 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$31,370

Medicare's payments for the services billed

Medicare patients

115

Average age 74

Services billed

255

60 women, 55 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 68%
Ischemic heart disease 66%
Diabetes 60%
Chronic kidney disease 60%
Arthritis 57%
COPD 56%
Atrial fibrillation 51%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

109 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Critical Care Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record